We are live on ! Find out more
CRC

Curi RMB Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 18.93%
This Fund
S&P 500
This Quarter Est. Return
-20.88%
1 Year Est. Return
+18.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+73.12%
10 Year Est. Return
+323.6%
AUM
$2.11B
AUM Growth
-$1.49B
Cap. Flow
-$763M
Cap. Flow %
-36.21%
Top 10 Hldgs %
18.35%
Holding
824
New
176
Increased
188
Reduced
239
Closed
177

Sector Composition

Rank Sector Weight
1 Financials 14.8%
2 Healthcare 14.35%
3 Technology 14.09%
4 Industrials 9.86%
5 Consumer Discretionary 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
501
Vertex Pharmaceuticals
VRTX
$126B
$286K 0.01%
1,203
-7,994
-87% -$1.83M
SMM
502
DELISTED
Salient Midstream & MLP Fund
SMM
$284K 0.01%
81,485
-32,421
-28% -$200K
CAT icon
503
Caterpillar
CAT
$387B
$281K 0.01%
2,421
-311
-11% -$39.7K
VBTX
504
DELISTED
Veritex Holdings
VBTX
$279K 0.01%
20,000
-581,880
-97% -$14M
GCAP
505
DELISTED
Gain Capital Holdings, Inc.
GCAP
$279K 0.01%
+50,000
New +$223K
OBK icon
506
Origin Bancorp
OBK
$1.66B
$276K 0.01%
13,639
-138,490
-91% -$4.33M
PCTI
507
DELISTED
PCTEL, Inc. Common Stock
PCTI
$275K 0.01%
+41,333
New +$315K
DCF
508
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$274K 0.01%
+42,973
New +$376K
VWO icon
509
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$271K 0.01%
8,091
-1,547
-16% -$63.1K
ASTE icon
510
Astec Industries
ASTE
$1.02B
$270K 0.01%
7,730
-625
-7% -$24.5K
IBB icon
511
iShares Biotechnology ETF
IBB
$9.77B
$270K 0.01%
2,506
OMC icon
512
Omnicom Group
OMC
$23.4B
$270K 0.01%
4,916
-590
-11% -$41.9K
PB icon
513
Prosperity Bancshares
PB
$8.89B
$265K 0.01%
5,500
-2,000
-27% -$130K
MNP
514
DELISTED
Western Asset Municipal Partners Fund, Inc.
MNP
$264K 0.01%
+19,316
New +$287K
PM icon
515
Philip Morris
PM
$295B
$257K 0.01%
3,532
-3,013
-46% -$248K
UL icon
516
Unilever
UL
$136B
$256K 0.01%
4,498
-178
-4% -$11.2K
PETQ
517
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$256K 0.01%
+11,009
New +$306K
ASML icon
518
ASML
ASML
$669B
$254K 0.01%
974
+29
+3% +$8.25K
USA icon
519
Liberty All-Star Equity Fund
USA
$1.85B
$254K 0.01%
52,500
AZN icon
520
AstraZeneca
AZN
$250B
$250K 0.01%
2,793
-206
-7% -$19.4K
FITB
521
Fifth Third Bancorp
FITB
$51.8B
$249K 0.01%
16,743
-12,714
-43% -$317K
FT
522
Franklin Universal Trust
FT
$197M
$248K 0.01%
+40,572
New +$299K
NQP
523
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$245K 0.01%
+18,377
New +$258K
KMF
524
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
$244K 0.01%
73,242
+30,000
+69% +$248K
RDS.A
525
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$244K 0.01%
7,001
-6,197
-47% -$289K

Similar funds

Curi RMB Capital's Q1 2020 Portfolio in Review

As of Q1 2020, Curi RMB Capital held 824 positions worth $2.11B, down 41% from $3.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Curi RMB Capital withdrew a net $763M in Q1 2020, closing 177 positions and reducing 239 holdings. Its most notable exit was SS&C Technologies, an estimated $21.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Curi RMB Capital opened a new position in iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036 worth $18.6M.

  • Curi RMB Capital's largest Q1 2020 buy was iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036: 1,124,937 shares worth $18.6M.
  • Curi RMB Capital added most to Carnival PLC in Q1 2020, an estimated $15.8M increase.
  • Curi RMB Capital's biggest Q1 2020 reduction was FB Financial Corp, cutting an estimated $16.4M.
  • Curi RMB Capital fully exited SS&C Technologies in Q1 2020, selling an estimated $21.6M.
  • Curi RMB Capital's ten largest holdings make up 18% of its $2.11B portfolio in Q1 2020.
  • Curi RMB Capital opened 176 new positions and closed 177 in Q1 2020.
  • Curi RMB Capital's portfolio value fell 41% quarter-over-quarter to $2.11B.

Based on Curi RMB Capital's 13F filing for Q1 2020, filed 11 May 2020.